Prosecution Insights
Last updated: October 25, 2026

Beth Israel Deaconess Medical Center Inc.

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

23 pending office actions • 22 art units • 22 examiners • 0 of 23 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days

Analysis

Beth Israel Deaconess Medical Center Inc. has 23 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 22 distinct examiners and 22 distinct art units, showing a widely distributed prosecution workload. One examiner therefore handles more than one matter, but the broader profile remains dispersed across examination resources.

TRAN, LARA LINH is the busiest examiner, with 2 pending actions. That concentration is modest relative to the overall workload, so counsel should prioritize centralized docket visibility and consistent scientific positions rather than rely on examiner-specific coordination. Each action still warrants an independent review of claim scope, references, and amendment consequences.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

23
Total Pending OAs
15
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
4
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (4)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

12
Hard (52%)
6
Medium (26%)
5
Easy (22%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (4%)
§101 + other4 (17%)
§103 only5 (22%)
§112 only4 (17%)
Double-patenting only1 (4%)
Double-patenting + other1 (4%)
Multi-statute (no §101)7 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
65% of docket
0
Information Tech
0% of docket
1
Communications
4% of docket
0
Semiconductors
0% of docket
7
Mechanical / Eng
30% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

230 h
Manual time on pending OAs
46 h
Time saved (low, 20%)
80 h
Time saved (mid, 35%)
2.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TRAN, LARA LINH 2 16.7% +90.9%
BALAJ, ANTHONY MICHAEL 1 31.2% +29.2%
GONZALEZ, LUISALBERTO 1 59.7% +46.3%
HAWTHORNE, OPHELIA ALTHEA 1 72.0% +30.2%
GEIGER, RACHAEL L 1 82.3% +18.3%
IVANOVA, SVETLANA M 1 50.9% +51.8%
BLACKSTEN, SYDNEY LYNN 1 100.0% +0.0%
LANDSMAN, ROBERT S 1 81.4% +13.0%
SITTON, JEHANNE SOUAYA 1 53.2% +47.5%
HOFFA, ANGELA MARIE 1 67.7% +28.1%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18409385 SYSTEM AND METHOD FOR IMAGE TEMPORAL INTERPOLATION FOR DYNAMIC IMAGING BLACKSTEN, SYDNEY LYNN 13d
18489525 METHODS FOR PREVENTING AND TREATING HEART DISEASE LANDSMAN, ROBERT S 56d

Hard Cases (12)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18274028 ELECTROPHORETIC MOBILITY SHIFT AS A MOLECULAR BEACON-BASED READOUT FOR MIRNA DETECTION SUN, CAITLYN MINGYUN 30d overdue
19314645 SYSTEM AND METHOD FOR ALGORITHMIC DIAGNOSTICS FOR EFFICIENT PRESCRIPTION OF TREATMENTS FOR B-SNIP PSYCHOSIS BIOTYPES BALAJ, ANTHONY MICHAEL —
18726658 THERMALLY ACTIVATED PESSARY HAWTHORNE, OPHELIA ALTHEA —
18752514 LYMPHATIC ANASTOMOSIS DEVICES AND METHODS GEIGER, RACHAEL L —
18700227 METHODS FOR TREATING A TRAUMA PATIENT IVANOVA, SVETLANA M —
18550008 Methods of Identifying Active Lupus Nephritis Flare SITTON, JEHANNE SOUAYA —
18254045 DEVICE AND METHOD FOR FENESTRATION ALIGNMENT TRAN, LARA LINH —
18133962 MICROSPHERE DELIVERY APPARATUS PROVIDING REAL-TIME MEASURING OF DELIVERED RADIOACTIVITY TRAN, LARA LINH —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18256739 Targeting Trancranial Magnetic Stimulation to Specific Brain Regions and Evaluating the Reduction of Symptoms of Psychotic Disorders HOFFA, ANGELA MARIE 9d
18934169 COMPOUNDS AND METHODS FOR USING GALLOYLATED POLYPHENOLS TO TREAT DISEASES MEDIATED BY THIOL ISOMERASES GONZALEZ, LUISALBERTO 27d
18489525 METHODS FOR PREVENTING AND TREATING HEART DISEASE LANDSMAN, ROBERT S 56d
19314645 SYSTEM AND METHOD FOR ALGORITHMIC DIAGNOSTICS FOR EFFICIENT PRESCRIPTION OF TREATMENTS FOR B-SNIP PSYCHOSIS BIOTYPES BALAJ, ANTHONY MICHAEL —
18726658 THERMALLY ACTIVATED PESSARY HAWTHORNE, OPHELIA ALTHEA —
18752514 LYMPHATIC ANASTOMOSIS DEVICES AND METHODS GEIGER, RACHAEL L —
18700227 METHODS FOR TREATING A TRAUMA PATIENT IVANOVA, SVETLANA M —
18550008 Methods of Identifying Active Lupus Nephritis Flare SITTON, JEHANNE SOUAYA —

Top Art Units

Art UnitApps
3791 2
3682 1
1624 1
3786 1
3771 1
1627 1
2674 1
1647 1
1682 1
3799 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19314645 SYSTEM AND METHOD FOR ALGORITHMIC DIAGNOSTICS FOR EFFICIENT PRESCRIPTION OF TREATMENTS FOR B-SNIP PSYCHOSIS BIOTYPES BALAJ, ANTHONY MICHAEL 3682 §101§103 Non-Final OA — Pending Aug 29, 2025
18934169 COMPOUNDS AND METHODS FOR USING GALLOYLATED POLYPHENOLS TO TREAT DISEASES MEDIATED BY THIOL ISOMERASES GONZALEZ, LUISALBERTO 1624 §112 Non-Final OA 27d Pending Oct 31, 2024
18726658 THERMALLY ACTIVATED PESSARY HAWTHORNE, OPHELIA ALTHEA 3786 §102§103 Non-Final OA — Pending Jul 03, 2024
18752514 LYMPHATIC ANASTOMOSIS DEVICES AND METHODS GEIGER, RACHAEL L 3771 §101§102§103 Non-Final OA — Pending Jun 24, 2024
18700227 METHODS FOR TREATING A TRAUMA PATIENT IVANOVA, SVETLANA M 1627 §103§112 Non-Final OA — Pending Apr 10, 2024
18409385 SYSTEM AND METHOD FOR IMAGE TEMPORAL INTERPOLATION FOR DYNAMIC IMAGING BLACKSTEN, SYDNEY LYNN 2674 §103 Final Rejection 13d Pending Jan 10, 2024
18489525 METHODS FOR PREVENTING AND TREATING HEART DISEASE LANDSMAN, ROBERT S 1647 §112DP Final Rejection 56d Pending Oct 18, 2023
18550008 Methods of Identifying Active Lupus Nephritis Flare SITTON, JEHANNE SOUAYA 1682 §101§102§103 Non-Final OA — Pending Sep 11, 2023
18256739 Targeting Trancranial Magnetic Stimulation to Specific Brain Regions and Evaluating the Reduction of Symptoms of Psychotic Disorders HOFFA, ANGELA MARIE 3799 §112 Final Rejection 9d Pending Jun 09, 2023
18254045 DEVICE AND METHOD FOR FENESTRATION ALIGNMENT TRAN, LARA LINH 3791 §102§103§112 Non-Final OA — Pending May 23, 2023
18133962 MICROSPHERE DELIVERY APPARATUS PROVIDING REAL-TIME MEASURING OF DELIVERED RADIOACTIVITY TRAN, LARA LINH 3791 §103§112 Non-Final OA — Pending Apr 12, 2023
18041271 ANTI-SEED PNAS AND MICRORNA INHIBITION MCCORMICK, CATHERINE LYNN 1638 §103 Final Rejection — Pending Feb 10, 2023
17781989 METHODS FOR DUAL DNA/PROTEIN TAGGING OF OPEN CHROMATIN FLINDERS, JEREMY C 1684 §112 Final Rejection — Pending Jun 02, 2022
17774338 DIAGNOSIS AND TREATMENT OF NAFLD AND LIVER FIBROSIS WALLENHORST, MAUREEN 1797 §101§112 Non-Final OA — Pending May 04, 2022
17765620 DIAGNOSIS AND TREATMENT OF THYROID CANCER GIAMMONA, FRANCESCA FILIPPA 1681 §103 Non-Final OA — Pending Mar 31, 2022
17291723 METHODS TO PREDICT LIVER DISEASE MORTALITY USING LIPOPROTEIN LP-Z PULLIAM, JOSEPH CONSTANTINE 1687 §101 Non-Final OA — Pending May 06, 2021
17250791 METHODS OF CULTURING PODOCYTES AND COMPOSITIONS THEREOF TRAN, KHOA NHAT 1632 §103§112 Final Rejection — Pending Mar 04, 2021
16324945 A20 THERAPY TO ACHIEVE GLYCEMIC CONTROL SHIN, DANA H 1635 §103 Final Rejection 15d Pending Feb 12, 2019
18771037 SYSTEM AND METHOD FOR CELL LEVITATION AND MONITORING PYLA, EVELYN Y 1633 DP Non-Final OA — Pending Jul 12, 2024
18570935 GLUTEN MODIFICATION STOCKDALE, JESSICA NICOLE 1663 §112 Final Rejection 55d Pending Dec 15, 2023
18274028 ELECTROPHORETIC MOBILITY SHIFT AS A MOLECULAR BEACON-BASED READOUT FOR MIRNA DETECTION SUN, CAITLYN MINGYUN 1795 §103§112 Non-Final OA 30d overdue Pending Jul 25, 2023
17926040 METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE WORSHAM, JESSICA N 1615 §103 Non-Final OA 44d overdue Pending Nov 17, 2022
15844440 LASER SURGICAL INSTRUMENT FOR SPINAL ENDOSCOPIC DECOMPRESSION WU, PAMELA F 3795 §103§112 Non-Final OA — Pending Dec 15, 2017

Managing Beth Israel Deaconess Medical Center Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Beth Israel Deaconess Medical Center Inc. have?

Beth Israel Deaconess Medical Center Inc. has 23 pending office actions as of October 2026, spread across 22 art units and 22 examiners.

Which USPTO examiner handles the most Beth Israel Deaconess Medical Center Inc. applications?

Lara Linh Tran has the most, with 2 of Beth Israel Deaconess Medical Center Inc.'s pending office actions.

What technology area are Beth Israel Deaconess Medical Center Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month